Genmab's Unattributed VC Round

Genmab raised a round of funding on June 14, 2000.

Genmab is an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.…

Articles about Genmab's Unattributed VC Round: